Pharmaceutical

Morning Rounds: Our newsroom’s favorite stories of 2023

Morning Rounds: Our newsroom’s favorite stories of 2023

Dec 23, 2023

Understand how science, health policy, and medicine shape the world everyday. Si...

The clock is ticking, and Cytokinetics is running out of December

The clock is ticking, and Cytokinetics is running out o...

Dec 23, 2023

Want to stay on top of the science and politics driving biotech today? Sign up t...

STAT+: Pharmalittle: Bristol Myers to buy schizophrenia-drug maker; Servier found guilty of fraud

STAT+: Pharmalittle: Bristol Myers to buy schizophrenia...

Dec 23, 2023

Bristol Myers agreed to pay $14 billion for Karuna Therapeutics, which has an ex...

STAT+: Bristol Myers to purchase Karuna, maker of schizophrenia drug, for $14 billion

STAT+: Bristol Myers to purchase Karuna, maker of schiz...

Dec 23, 2023

Bristol Myers Squibb said Friday that it will acquire Karuna Therapeutics, a dev...

Opinion: The unique pain and joy of celebrating Christmas with a child in the pediatric intensive care unit

Opinion: The unique pain and joy of celebrating Christm...

Dec 23, 2023

“Every Christmas since my daughter died, I have tried to run away from those mem...

STAT+: AAFP’s CEO on how to keep primary care doctors in the field

STAT+: AAFP’s CEO on how to keep primary care doctors i...

Dec 23, 2023

“Family medicine and primary care's obituary has been written many times in my 2...

3 issues to watch in global health in 2024

3 issues to watch in global health in 2024

Dec 23, 2023

In the world of infectious diseases and global health, if it’s not one thing, it...

STAT+: FDA approves AstraZeneca, Ionis treatment for rare nerve disease

STAT+: FDA approves AstraZeneca, Ionis treatment for ra...

Dec 23, 2023

The drug is a monthly injection for a genetic disorder called ATTR-PN, which aff...

Cadonilimab by Akeso for Esophageal Squamous Cell Carci...

Dec 22, 2023

Cadonilimab is under clinical development by Akeso and currently in Phase II for...

SOR-007 by Nanology for Metastatic Adenocarcinoma of Th...

Dec 22, 2023

SOR-007 is under clinical development by Nanology and currently in Phase II for ...

MRNA-2752 by Moderna for Transitional Cell Cancer (Urot...

Dec 22, 2023

MRNA-2752 is under clinical development by Moderna and currently in Phase I for ...

Imvotamab by IGM Biosciences for Rheumatoid Arthritis: ...

Dec 22, 2023

Imvotamab is under clinical development by IGM Biosciences and currently in Phas...

XB-002 by Exelixis for Breast Cancer: Likelihood of App...

Dec 22, 2023

XB-002 is under clinical development by Exelixis and currently in Phase II for B...

Iruplinalkib by Qilu Pharmaceutical for Solid Tumor: Li...

Dec 22, 2023

Iruplinalkib is under clinical development by Qilu Pharmaceutical and currently ...

Runimotamab by Genentech USA for Solid Tumor: Likelihoo...

Dec 22, 2023

Runimotamab is under clinical development by Genentech USA and currently in Phas...

IDE-161 by Ideaya Biosciences for Metastatic Ovarian Ca...

Dec 22, 2023

IDE-161 is under clinical development by Ideaya Biosciences and currently in Pha...